Skip to main content

Rein Therapeutics, Inc.

RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001420565

No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Rein Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
33
−3 vs. Q2 2022
Shares held
28.3M
−3.75M (−11.7%) vs. Q2 2022
Total value
$5.86M
−$2.48M (−29.7%) vs. Q2 2022
New holders
4
8 more added
Sold out
7
5 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 33 institutions
Q1 2021: 52 institutionsQ2 2021: 47 institutionsQ3 2021: 43 institutionsQ4 2021: 43 institutionsQ1 2022: 42 institutionsQ2 2022: 37 institutionsQ3 2022: 33 institutionsQ4 2022: 19 institutionsQ1 2023: 19 institutionsQ2 2023: 17 institutionsQ3 2023: 16 institutionsQ4 2023: 20 institutionsQ1 2024: 23 institutionsQ2 2024: 29 institutionsQ3 2024: 32 institutionsQ4 2024: 31 institutionsQ1 2025: 39 institutionsQ2 2025: 36 institutionsQ3 2025: 40 institutionsQ4 2025: 48 institutionsQ1 2026: 46 institutionsQ2 2026: 59 institutions
Value heldQ3 2022: $5.86M
Q1 2021: $48.0MQ2 2021: $41.5MQ3 2021: $33.6MQ4 2021: $18.9MQ1 2022: $16.5MQ2 2022: $8.34MQ3 2022: $5.86MQ4 2022: $3.21MQ1 2023: $1.30MQ2 2023: $1.83MQ3 2023: $1.59MQ4 2023: $3.24MQ1 2024: $11.0MQ2 2024: $13.5MQ3 2024: $16.3MQ4 2024: $13.1MQ1 2025: $10.6MQ2 2025: $9.30MQ3 2025: $9.76MQ4 2025: $12.5MQ1 2026: $14.8MQ2 2026: $42.3M
Institutions holding RNTX and their total value by quarter
QuarterHoldersValue
Q2 202659$42.3M
Q1 202646$14.8M
Q4 202548$12.5M
Q3 202540$9.76M
Q2 202536$9.30M
Q1 202539$10.6M
Q4 202431$13.1M
Q3 202432$16.3M
Q2 202429$13.5M
Q1 202423$11.0M
Q4 202320$3.24M
Q3 202316$1.59M
Q2 202317$1.83M
Q1 202319$1.30M
Q4 202219$3.21M
Q3 202233$5.86M
Q2 202237$8.34M
Q1 202242$16.5M
Q4 202143$18.9M
Q3 202143$33.6M
Q2 202147$41.5M
Q1 202152$48.0M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q2 2022.

Institutions holding RNTX in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Satter Management Co., L.P.16,609,449$3.43M3.31%00.0%Unchanged
BVF Inc5,265,555$1.09M0.04%00.0%Unchanged
Vanguard Group Inc2,605,107$539.0K0.00%−488,121−15.8%Reduced
Blair William & Co1,226,792$254.0K0.00%+78,211+6.8%Added
Geode Capital Management, LLC886,422$183.0K0.00%+13,365+1.5%Added
KCK Ltd.446,817$101.0K0.20%−200,000−30.9%Reduced
Renaissance Technologies LLC190,691$39.0K0.00%+75,500+65.5%Added
Envestnet Asset Management Inc184,022$38.0K0.00%+63,651+52.9%Added
PVG Asset Management Corp117,600$24.3K0.09%+117,600New
Northern Trust Corp113,802$24.0K0.00%00.0%Unchanged
State Street Corp102,083$21.0K0.00%00.0%Unchanged
Game Plan Financial Advisors, LLC100,000$21.0K0.02%−3,000−2.9%Reduced
Colony Group LLC90,318$19.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.66,457$14.0K0.00%+24,252+57.5%Added
Susquehanna International Group, LLP50,429$10.0K0.00%+50,429New
JFS Wealth Advisors, LLC31,807$7.00K0.00%00.0%Unchanged
Kestra Advisory Services, LLC30,000$6.00K0.00%00.0%Unchanged
US Bancorp25,000$5.00K0.00%00.0%Unchanged
Morgan Stanley25,027$5.00K0.00%+27+0.1%Added
Cetera Investment Advisers26,236$5.00K0.00%+8,739+49.9%Added
Mercer Global Advisors Inc20,096$4.00K0.00%00.0%Unchanged
LPL Financial LLC20,000$4.00K0.00%+10,000+100.0%Added
Lake Street Advisors Group, LLC16,500$3.00K0.00%−2,000−10.8%Reduced
Kore Private Wealth LLC11,183$2.00K0.00%00.0%Unchanged
Ridgecrest Wealth Partners, LLC10,000$2.00K0.00%00.0%Unchanged
Millennium Management LLC11,999$2.00K0.00%+11,999New
Bank of America Corp3,700$1.00K0.00%00.0%Unchanged
BlackRock Inc.3,799$1.00K0.00%00.0%Unchanged
UBS Group AG2,000$00.00%00.0%Unchanged
Wells Fargo & Company440$00.00%−4−0.9%Reduced
Acadian Asset Management LLC344$00.00%00.0%Unchanged
Rockefeller Capital Management L.P.1,000$00.00%00.0%Unchanged
FNY Investment Advisers, LLC1,000$00.00%+1,000New
Ikarian Capital, LLC0$00.00%−2,892,316−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−278,743−100.0%Sold out
Taconic Capital Advisors LP0$00.00%−135,000−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−75,078−100.0%Sold out
Jane Street Group, LLC0$00.00%−75,830−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−33,690−100.0%Sold out
Virtu Financial LLC0$00.00%−20,605−100.0%Sold out
Urban Wealth Management, LLC––––Not filed